Food and Drug Administration staff cuts may hinder US biomedical innovation

The elimination of 3,500 full-time employees astatine the FDA risks undermining the precise innovation and home capableness the president seeks to promote, and could pb to a nonaccomplishment of American capital, concern and jobs.